文献速递临床试验与 GCP

眼动脱敏与再加工治疗联合多焦经颅电流刺激作为纤维肌痛患者增效策略的双盲随机对照试验研究方案

The study protocol of a double-blind randomized controlled trial of EMDR and multifocal transcranial current stimulation (MtCS) as augmentation strategy in patients with fibromyalgia.
PubMed 文献 · Trials · 2024-12-31

本双盲随机对照试验拟纳入96例有创伤事件史的纤维肌痛患者,随机分配至常规治疗组、EMDR联合活性多焦经颅电流刺激组或EMDR联合伪刺激组,评估EMDR能否减轻疼痛症状及多焦经颅电流刺激能否增强其效果。

要点

  • 纤维肌痛影响普通人群2.7%,与心理创伤密切相关。
  • 96例患者随机分至常规治疗、EMDR联合活性刺激或EMDR联合伪刺激三组。
  • 评估时间点为基线、治疗后及治疗后6个月随访。

核心结论

  • 本研究将提供证据说明EMDR治疗能否有效减轻纤维肌痛患者的疼痛症状,以及多焦经颅电流刺激能否增强EMDR的效果。

研究设计与样本

  • 双盲随机对照试验,纳入96例有创伤事件史的纤维肌痛患者,随机分配至常规治疗组、EMDR联合活性多焦经颅电流刺激组或EMDR联合伪多焦经颅电流刺激组。
  • 治疗师和患者对多焦经颅电流刺激条件保持盲态,评估者对EMDR和多焦经颅电流刺激均保持盲态。

关键数值与推荐

  • 所有患者在基线、治疗后及治疗后6个月随访时接受评估。
  • 评估变量包括社会人口学数据、疼痛、心理创伤、睡眠障碍、焦虑和情感症状、幸福感、自我照护、情绪调节、自尊和认知功能。
  • 该试验于2019年8月2日在ClinicalTrials.gov注册,注册号NCT04084795。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fibromyalgia (FM) is a generalized, widespread chronic pain disorder affecting 2.7% of the general population. In recent years, different studies have observed a strong association between FM and psychological trauma. Therefore, a trauma-focused psychotherapy, such as Eye Movement Desensitization and Reprocessing (EMDR), combined with a non-invasive brain stimulation technique, such as multifocal transcranial current stimulation (MtCS), could be an innovative adjunctive treatment option. This double-blind randomized controlled trial (RCT) analyzes if EMDR therapy is effective in the reduction of pain symptoms in FM patients, and if its potential is boosted with the addition of MtCS. METHODS: Ninety-six patients with FM and a history of traumatic events will be randomly allocated to the treatment as usual (TAU) condition, EMDR + active-MtCS condition, or EMDR + sham-MtCS condition. Therapists and patients will be kept blind to MtCS conditions, and raters will be kept blind to both EMDR and MtCS. All patients will be evaluated at baseline, post-treatment, and follow-up at 6 months after post-treatment. Evaluations will assess the following variables: sociodemographic data, pain, psychological trauma, sleep disturbance, anxiety and affective symptoms, wellbeing, self-care, emotional regulation, self-esteem, and cognitive functioning. DISCUSSION: This study will provide evidence of whether EMDR therapy is effective in reducing pain symptoms in FM patients, and whether the effect of EMDR can be enhanced by MtCS. TRIAL REGISTRATION NUMBER: This trial was registered at ClinicalTrials.gov on 2 August 2019, identifier: NCT04084795.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Gardoki-Souto I, Martín de la Torre O, Hogg B, et al. The study protocol of a double-blind randomized controlled trial of EMDR and multifocal transcranial current stimulation (MtCS) as augmentation strategy in patients with fibromyalgia. Trials. 2024. PMID: 39741323. doi:10.1186/s13063-024-08708-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。